The effect of low and high plasma levels of insulin-like growth factor-1 (IGF-1) on the morphology of major organs: Studies of laron dwarf and bovine growth hormone transgenic (bGHTg) mice

Histology and Histopathology

Volumn 28, Issue 10, 2013, Pages 1325-1336

  Piotrowska, Katarzyna ^a   Borkowska, Sylwia J ^a   Wiszniewska, Barbara ^a   Laszczyńska, Maria ^a   Słuczanowska Głabowska, Sylwia ^a   Havens, Aaron M ^c   Kopchick, John J ^d   Bartke, Andrzej ^e   Taichman, Russel S ^c   Kucia, Magda ^b   Ratajczak, Mariusz Z ^a,b  

^a POMERANIAN MEDICAL UNIVERSITY   (Poland)

^b UNIVERSITY OF LOUISVILLE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d OHIO UNIVERSITY   (United States)

^e SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Brown adipose tissue; Growth hormone (GH); Insulin like growth factor 1 (IGF 1); Laron dwarf mice

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE, BOVINE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOENOLPYRUVATE CARBOXYKINASE 1 (SOLUBLE) PROTEIN, RAT; SIGNAL PEPTIDE; SOMATOMEDIN C;

ANIMAL; ARTICLE; BIOSYNTHESIS; BROWN ADIPOSE TISSUE; CATTLE; CYTOLOGY; DENSITOMETRY; FATTY LIVER; GENETICS; KIDNEY; KNOCKOUT MOUSE; LEUKOCYTE; LIVER; LIVER CELL; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; PLASMA; RAT; SPLEEN; TIME; TISSUE DISTRIBUTION; TRANSGENIC MOUSE;

ADIPOSE TISSUE, BROWN; ANIMALS; CATTLE; DENSITOMETRY; FATTY LIVER; GROWTH HORMONE; HEPATOCYTES; INSULIN-LIKE GROWTH FACTOR I; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; LEUKOCYTES; LIVER; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PLASMA; RATS; SPLEEN; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 84885347104     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Bartke A. (2008). Insulin and aging. Cell Cycle 7, 3338-3343.
2. Bartke A., Chandrashekar V., Bailey B., Zaczek D. and Turyn D. (2002). Concequences of growth hormone (GH) overexpression and GH resistance. Neuropeptides 36, 201-208.
3. Blazar B.R., Brennan C.A., Broxmeyer H.E., Shultz L.D. and Vallera D.A. (1995). Transgenic mice expressing either bovine growth hormone (bGH) or human GH releasing hormone (hGRH) have increased splenic progenitor cell colony formation and DNA synthesis in vitro and in vivo. Exp. Hematol. 23, 1397-1406.
4. Brunt E.M. and Tiniakos D.G. (2010). Histopathology of nonalcoholic fatty liver disease. World J. Gastroenterol. 16, 5286-5296.
5. Bulum T., Kolariç B., Duvnjak L. and Duvnjak M. (2011). Nonalcoholic Fatty Liver Disease Markers Are Associated with Insulin Resistance in Type 1 Diabetes. Dig. Dis. Sci. 56, 3655-3663.
6. Cannon B. and Nedergaard J. (2004). Brown adipose tissue: function and physiological significance. Physiol. Rev. 84, 277-359.
7. Clayton P.E., Banerjee I., Murray P.G. and Renehan A.G. (2011). Growth hormone, the insulin-like growth factor axis, insulin and cancer risk. Nat. Rev. Endocrinol. 7, 11-24.
8. Coschigano K.T., Wetzel A.N., Obichere N., Sharma A., Lee S., Rasch R., Guigneaux M.M., Flyvbjerg A., Wood T.G. and Kopchick J.J. (2010). Identification of differentially expressed genes in the kidneys of growth hormone transgenic mice. Growth Horm. IGF Res. 20, 345-355.
9. Cousin B., Cinti S., Morroni M., Raimbault S., Ricquier D., Pénicaud L. and Casteilla L. (1992). Occurrence of brown adipocytes in rat white adipose tissue: molecular and morphological characterization. J. Cell. Sci. 103, 931-942.
10. Flurkey K., Papaconstantinou J., Miller R.A. and Harrison D.E. (2001). Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. USA 98, 6736-6741.
11. Fontana L., Weiss E.P., Villareal D.T., Klein S. and Holloszy J.O. (2008). Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell. 7, 681-687.
12. Gesing A., Bartke A., Wang F., Karbownik-Lewinska M. and Masternak M.M. (2011). Key regulators of mitochondrial biogenesis are increased in kidneys of growth hormone receptor knockout (GHRKO) mice. Cell Biochem. Funct. 66, 459-467.
13. Ghosh P.M., Shu Z.J., Zhu B., Lu Z., Barnes J.L., Yeh C.K., Zhang B.X., Katz M.S. and Kamat A. (2012). Role of ß-adrenic receptors in regulation of hepatic fat accumulation during aging. J. Endocrinol. 213, 251-261.
14. Gregg S.Q., Gutiérrez V., Rasile Robinson A., Woodell T., Nakao A., Ross M.A., Michalopoulos G.K., Rigatti L., Rothermel C.E., Kamileri I., Garinis G.A., Beer Stolz D. and Niedernhofer L.J. (2012). A mouse model of accelerated liver aging caused by a defect in DNA repair. Hepatology 55, 609-621.
15. Grunenwald S., Tack I., Chauvaeau D., Bennet A. and Caron P. (2011). Impact of growth hormone hypersecretion on the adult human kidney. Ann. Endocrinol. (Paris) 71, 485-495.
16. Harper J.M., Salmon A.B., Leiser S.F., Galecki A.T. and Miller R.A. (2007). Skin-derived fibroblasts from long-lived species are resistant to some, but not all, lethal stresses and to the mitochondrial inhibitor rotenone. Aging Cell. 6, 1-13.
17. Hemmeryckx B., Hoylaerts M.F. and Lijenen H.R. (2012). Effect of premature aging on murine adipose tissue. Exp. Gerontol. 47, 256-262.
18. Ikeno Y., Hubbard G.B., Lee S., Cortez L.A., Lew C.M., Webb C.R., Berryman D.E., List E.O., Kopchick J.J. and Bartke A. (2009). Reduced incidence and delayed occurrence of fatal neoplastic diseases in growth hormone receptor/binding protein knockout mice. J. Gerontol. A. Biol. Sci. Med. Sci. 64, 522-529.
19. Kenyon C.J. (2010). The genetics of aging. Nature 464, 504-512.
20. Kinney B.A., Coschigano K.T., Kopchick J.J., Steger R.W. and Bartke A. (2001). Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice. Physiol. Behav. 72, 653-660.
21. Kucia M., Masternak M., Liu R., Shin D.M., Ratajczak J., Mierzejewska K., Spong A., Kopchick J.J., Bartke A. and Ratajczak M.Z. (2013). The negative effect of prolonged somatotrophic/insulin signaling on an adult bone marrow-residing population of pluripotent very small embryonic-like stem cells (VSELs). Age (Dordr). 35, 315-330.
22. Maronpot R.R., Boorman G.A. and Gaul B.W. (1999). Pathology of the mouse. Cache River Press. Vienna. IL.
23. Mattson M.P. (2010). Perspective: Does brown fat protect against diseases of aging? Aging Res. Rev. 9, 69-76.
24. McGrane M.M., de Vente J., Yun J., Bloom J., Park E., Wynshaw-Boris A., Wagner T., Rottman F.M., Hanson R.W. (1988). Tissue-specific expression and dietary regulation of a chimeric phosphoenolpyruvate carboxykinase/bovine growth hormone gene in transgenic mice. J. Biol. Chem. 263, 11443-11451.
25. Merat S., Khadem-Sameni F., Nouraie M., Derakhshan M.H., Tavangar S.M., Mossaffa S., Malekzadeh R. and Sotoudeh M. (2010). A modification of the Brunt system for scoring liver histology of patients with non-Alcoholic Fatty Liver Disease. Arch. Iran Med. 13, 38-44.
26. Miquet J.G., González L., Matos M.N., Hansen C.E., Louis A., Bartke A., Turyn D. and Sotelo A.I. (2008). Transgenic mice overexpressing GH exhibit hepatic upregulation of GH-signaling mediators involved in cell proliferation. J. Endocrinol. 198, 317-330.
27. Olsson B., Bohlooly Y.M., Brusehed O., Isaksson O.G., Ahrén B., Olofsson J. and Törnell J. (2003). Bovine growth hormone - transgenic mice have major alternations in hepatic expression of metabolic genes. Am. J. Physiol. Endocrinol. Metab. 285, E504-511.
28. Palmer A.J., Chung M.Y., List E.O., Walker J., Okada S., Kopchick J.J. and Berryman D.E. (2009). Age-related changes in body composition of bovine growth hormone transgenic mice. Endocrinology 150, 1353-1360.
29. Piper M.D. and Bartke A. (2008). Diet and aging. Cell Metab. 8, 99-104.
30. Piper M.D.W., Selman C., McElwee J.J. and Partridge L. (2008). Separating cause from effect: how does insulin/IGF signaling control lifespan in worms, flies and mice? J. Intern. Med. 263, 179-191.
31. Qian Y., Feldman E., Pennathur S., Kretzler M. and Brosius F.C. 3rd. (2008). From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes 57, 1439-1445.
32. Ratajczak J., Shin D.M., Wan W., Liu R., Masternak M.M., Piotrowska K., Wiszniewska B., Kucia M., Bartke A. and Ratajczak M.Z. (2011). Higher number of stem cells in the bone marrow of circulating low Igf-1 level Laron dwarf mice-novel view on Igf-1, stem cells and aging. Leukemia 25, 729-733.
33. Salmon A.B., Murakami S., Bartke A., Kopchick J., Yasumura K. and Miller R.A. (2005). Fibroblast cell lines from young adult mice of long-lived mutant strains are resistant to multiple forms of stress. Am. J. Physiol. Endocrinol. Metab. 289, E23-29.
34. Schulz T.J., Huang T.L., Tran T.T., Zhang H., Townsend K.L., Shadrach J.L., Cerletti M., McDougall L.E., Giorgadze N., Tchkonia T., Schrier D., Falb D., Kirkland J.L., Wagers A.J. and Tseng Y.H. (2011). Identification of inducible brown adipocyte progenitors residing in skeletal muscle and white fat. Proc. Natl. Acad. Sci. USA 108, 143-148.
35. Singh P., Coskun Z.Z., Goode C., Dean A., Thompson-Snipes L. and Darlington G. (2008). Lymphoid neogenesis and immune infiltration in aged liver. Hepatology 47, 1680-1690.
36. Sluczanowska-Glabowska S., Laszczynska M., Piotrowska K., Glabowski W., Kopchick J.J., Bartke A., Kucia M. and Ratajczak M.Z. (2012). Morphology of ovaries in laron dwarf mice, with low circulating plasma levels of insulin-like growth factor-1 (IGF-1), and in bovine GH-transgenic mice, with high circulating plasma levels of IGF-1. J. Ovarian Res. 5, 18.
37. Snibson K.J. (2002). Hepatocellular kinetics and the expression of growth hormone (GH) in the livers and liver tumors of GH-transgenic mice. Tissue Cell 34, 88-97.
38. Wu D. and Meydani S.N. (2008). Age-associated changes in immune and inflammatory responses: impact of vitamin E intervention. J. Leukoc. Biol. 84, 900-914.
39. Zhou Y., Xu B.C., Maheshwari H.G., He L., Reed M., Lozykowski M., Okada S., Cataldo L., Coschigano K., Wagner T.E., Baumann G. and Kopchick J.J. (1997). A mammalian model for Laron syndrome produced by target disruption of the mouse growth hormone receptor/binding protein gene (Laron mouse). Proc. Natl. Acad. Sci. 94, 13215-13220.